Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency

Kidney International

Volumn 61, Issue 2, 2002, Pages 555-563

  Mackie, Fiona E ^a,b,c   Meyer, Timothy W ^a,b,c   Campbell, Duncan J ^a,b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b St Vincent's Public Hospital   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Bradykinin; Hypertension; Losartan; Nifedipine; Proteinuria; Remnant kidney; Renal failure; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; BRADYKININ; ENALAPRIL; LOSARTAN; NIFEDIPINE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFECT; HEMOCONCENTRATION; HYPERTENSION; KIDNEY; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; TISSUE LEVEL; TREATMENT OUTCOME;

EID: 0036151567     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00141.x     Document Type: Article

References (41)

1. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
2. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: Rein follow-up trial. Ramipril Efficacy in Ne-phropathy
3. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass
4. Short and long term effect of angiotensin II receptor blockade in rats with experimental diabetes
5. Losartan reduces albuminuria in patients with essential hypertension: An enalapril controlled 3 months study
6. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
7. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
8. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus
9. Comparison of losartan and amlodipine in renally impaired hypertensive patients
10. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
11. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
12. Preservation of renal function in the rat remnant kidney model of chronic renal failure by blood pressure reduction
13. Class differences in the effects of calcium channel blockers in the rat remnant kidney model
14. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys
15. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model
16. Reversing glomerular hypertension stabilizes established glomerular injury
17. Renin expression in renal ablation
18. Bradykinin peptides in kidney, blood and other tissues of the rat
19. Nephrectomy, converting enzyme inhibition and angiotensin peptides
20. Design of rat renin inhibitory peptides
21. Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency
22. Losartan sensitive renal damage caused by chronic NOS inhibition does not involve increased renal ANG II concentration
23. Progressive glomerular injury after limited renal infarction in the rat
24. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury
25. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
26. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats
27. Blood pressure-independent effects in rats with human renin and angiotensinogen genes
28. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis
29. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat
30. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme
31. Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT 1 receptor
32. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity
33. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides
34. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats
35. Bioregulation of kinins: Kallikreins, kininogens, and kininases
36. Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene
37. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors
38. Renovascular hypertension in bradykinin B2-receptor knockout mice
39. Role of kinins in the control of renal papillary blood flow, pressure natriuresis, and arterial pressure
40. Comparison of B1 and B2 receptor activation on intracellular calcium, cell proliferation, and extracellular collagen secretion in mesangial cells from normal and diabetic rats
41. 1 receptor mediated changes in renal hemodynamics during endotoxin- induced inflammation